{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T17:45:28Z","timestamp":1788111928422,"version":"build-2803163510"},"reference-count":69,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Dutch Ministry of Health, Welfare and Sports"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.yrtph.2011.01.006","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T04:26:18Z","timestamp":1295670378000},"page":"423-429","source":"Crossref","is-referenced-by-count":168,"title":["Harm potential of magic mushroom use: A review"],"prefix":"10.1016","volume":"59","author":[{"given":"Jan van","family":"Amsterdam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoon","family":"Opperhuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wim van den","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2011.01.006_b0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0893-133X(95)00136-2","article-title":"The psychopharmacology of hallucinogens","volume":"14","author":"Abraham","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yrtph.2011.01.006_b0010","series-title":"Licit and illicit drug use in the Netherlands 2001","author":"Abraham","year":"2002"},{"key":"10.1016\/j.yrtph.2011.01.006_b0015","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/02770906509106904","article-title":"Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects","volume":"3","author":"Abramson","year":"1965","journal-title":"J. Asthma Res."},{"key":"10.1016\/j.yrtph.2011.01.006_b0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/02791072.1988.10472518","article-title":"A private inquiry into the circumstances surrounding the 1972 death of John Gomilla, Jr., who died after allegedly consuming ten hallucinogenic mushrooms while residing in Hawaii","volume":"20","author":"Allen","year":"1988","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.yrtph.2011.01.006_b0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/02791072.1991.10472573","article-title":"An ethnomycological review of psychoactive agarics in Australia and New Zealand","volume":"23","author":"Allen","year":"1991","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.yrtph.2011.01.006_b0030","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1037\/1064-1297.2.3.244","article-title":"Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey","volume":"2","author":"Anthony","year":"1994","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.yrtph.2011.01.006_b0035","series-title":"Tragic Flying Attempt Under the Influence of \u201cMagic Mushrooms\u201d. Laboratoire National de Sant\u00e9, Division Toxicologie, CRP-Sant\u00e9","author":"Asselborn","year":"1999"},{"key":"10.1016\/j.yrtph.2011.01.006_b0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jat\/22.1.45","article-title":"Presence of phenylethylamine in hallucinogenic psilocybe mushroom: possible role in adverse reactions","volume":"22","author":"Beck","year":"1998","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.yrtph.2011.01.006_b0045","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1136\/bmj.1.6174.1319","article-title":"Persistent psychiatric symptoms after eating psilocybin mushrooms","volume":"1","author":"Benjamin","year":"1979","journal-title":"Br. Med. J."},{"key":"10.1016\/j.yrtph.2011.01.006_b0050","unstructured":"Black Poppy., 2006. The Fly Agaric Mushroom, Black Poppy: a drug users health and lifestyle magazine, issue 11. Website: <http:\/\/www.blackpoppy.org.uk\/science_flyargaric.html> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0055","unstructured":"Bosch, J.A., Pennings, E.J.M., de Wolff, F.A., 1997. Psychoactieve paddestoel and plantproducten; toxicologie en klinische effecten. Report to the Ministry of Health."},{"key":"10.1016\/j.yrtph.2011.01.006_b0060","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2307\/3756309","article-title":"Mushroom poisoning since 1924 in United States","volume":"53","author":"B\u00fcck","year":"1961","journal-title":"Mycologia"},{"key":"10.1016\/j.yrtph.2011.01.006_b0065","unstructured":"Buster, M, van Brussel, G., 2007. Acute medische hulp in verband met incidenten door het gebruik van roesmiddelen in Amsterdam, 2007. Een stijgende trend van paddo-incidenten. GG&GD Amsterdam (Amsterdam Municipal Health Service). Website: <http:\/\/www.gezond.amsterdam.nl\/GetDocument.ashx?DocumentID=2371&name=Acute-medische-hulp-paddo-incidenten&rnd=634246864103392254> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0070","unstructured":"CAM., 2000. Risk Assessment report relating to paddos (psilocin and psilocybin). Coordination Centre for the Assessment and Monitoring of New Drugs (CAM), Den Haag, The Netherlands. Website: <www.rivm.nl\/bibliotheek\/digitaaldepot\/cam_paddo_advies.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0075","unstructured":"CAM. 2007. Report of Coordination point Assessment and Monitoring new drugs (CAM). Aanvullende informatie paddoincidenten in Amsterdam. Website: <http:\/\/www.rivm.nl\/bibliotheek\/digitaaldepot\/cam_paddo_aanvulling.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0080","first-page":"283","article-title":"User perceptions of the benefits and harms of hallucinogenic drug use: a web-based questionnaire study","volume":"15","author":"Carhart-Harris","year":"2010","journal-title":"J. Subst. Abuse"},{"key":"10.1016\/j.yrtph.2011.01.006_b0085","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.npp.1300621","article-title":"Modulating the rate and rhythmicity of perceptual rivalry alternations with the mixed 5-HT2A and 5-HT1A agonist psilocybin","volume":"30","author":"Carter","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.yrtph.2011.01.006_b0090","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0196-0644(85)80643-0","article-title":"Intravenous mushroom poisoning","volume":"14","author":"Curry","year":"1985","journal-title":"Ann. Emerg. Med."},{"key":"10.1016\/j.yrtph.2011.01.006_b0095","unstructured":"De Gelderlander. 2-10-2008. Website: <http:\/\/www.gelderlander.nl\/voorpagina\/nijmegen\/3913766\/Waarschuwing-na-xtcdode-in-Nijmegen.ece> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0100","unstructured":"De Telegraaf. 3-8-2008. Website: <http:\/\/www.telegraaf.nl\/binnenland\/1611897\/__Weer_dodelijke_paddo-sprong__.html> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0105","unstructured":"Erowid., 2006. Erowid. Website: <http:\/\/www.erowid.org>. Dated: 25.03.2006."},{"key":"10.1016\/j.yrtph.2011.01.006_b0110","unstructured":"European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Hallucinogenic mushrooms: an emerging trend case study. Website: <http:\/\/www.emcdda.europa.eu\/html.cfm\/index31208EN.html> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0115","unstructured":"Expatica Communications B.V., 2008. <http:\/\/www.expatica.com\/nl\/news\/local_news\/Netherlands-bans-magic-mushrooms_47271.html>. Retrieved November 2010."},{"key":"10.1016\/j.yrtph.2011.01.006_b0120","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/379733a0","article-title":"Inhibition of monoamine oxidase B in the brains of smokers","volume":"379","author":"Fowler","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yrtph.2011.01.006_b0125","unstructured":"Gerault, A, Picart, D., 1996. Intoxication mortelle a la suite de la consommation volontaire et en groupe de champignons hallucinogenes [Fatal Poisoning After a Group of People Voluntarily Consumed Hallucinogenic Mushrooms]. Bull. Soc. Mycol. Franc 112, 1-14. Website: <http:\/\/www.lycaeum.org\/leda\/docs\/10488.shtml?ID=10488> (retrieved January 2011)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0130","first-page":"350","article-title":"Fatal Ingestion of magic mushroom: a case report","volume":"14","author":"Gonmori","year":"2002","journal-title":"Ann. Toxicol. Anal."},{"key":"10.1016\/j.yrtph.2011.01.006_b0135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00008877-199811000-00011","article-title":"Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans","volume":"9","author":"Gouzoulis-Mayfrank","year":"1998","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.yrtph.2011.01.006_b0140","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s002130050860","article-title":"Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers. Results of an experimental double-blind placebo-controlled study","volume":"142","author":"Gouzoulis-Mayfrank","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.yrtph.2011.01.006_b0145","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.yrtph.2011.01.006_b0150","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0376-8716(98)00129-X","article-title":"Do hallucinogens cause residual neuropsychological toxicity?","volume":"53","author":"Halpern","year":"1999","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.yrtph.2011.01.006_b0155","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0376-8716(02)00306-X","article-title":"Hallucinogen persisting perception disorder: what do we know after 50years?","volume":"69","author":"Halpern","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.yrtph.2011.01.006_b0160","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose-effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.yrtph.2011.01.006_b0165","unstructured":"Hibell, B, Andersson, B, Bjarnasson, T, Ahlstr\u00f6m, S, Balakivari, O, Kokevi, A, Morgan, M., 2003. The 2003 ESPAD Report; Alcohol and Other Drug Use Among Students in 35 European Countries. Stockholm. Website: <http:\/\/www.sedqa.gov.mt\/pdf\/information\/reports_intl_espad2003.pdf>."},{"key":"10.1016\/j.yrtph.2011.01.006_b0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00407974","article-title":"Cross tolerance between LSD and psilocybin","volume":"2","author":"Isbell","year":"1961","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.yrtph.2011.01.006_b0175","unstructured":"Jacob, M.R., Fehr, K.O.B., 1987. Drugs and drug abuse: a reference text, second ed. Toronto, Addiction Research Foundation, quoted through Neuroscience of psychoactive substance use and dependence, (2004) WHO, Geneva: pp. 104\u2013105."},{"key":"10.1016\/j.yrtph.2011.01.006_b0180","unstructured":"KLPD. 2007. Briefing J. van der Klein, N. de Bruin, Korps Landelijke Politiediensten, May 2007."},{"key":"10.1016\/j.yrtph.2011.01.006_b0185","unstructured":"Korf, D.J., Nabben, T., 2007. Briefing of Bongers Institute, University of Amsterdam."},{"key":"10.1016\/j.yrtph.2011.01.006_b0190","first-page":"357","article-title":"Drug abuse in Slovak Republic","volume":"62","author":"Kresanek","year":"2005","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.yrtph.2011.01.006_b0195","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/00005053-196312000-00007","article-title":"Reactions to psilocybin administered in a supportive environment","volume":"137","author":"Leary","year":"1963","journal-title":"J. Nerv. Mental Dis."},{"key":"10.1016\/j.yrtph.2011.01.006_b0200","unstructured":"Levitt, R, Nason, E, Hallsworth, M., 2006. The Rand Corporation. The evidence base for the classification of drugs. Website: <http:\/\/www.rand.org\/pubs\/technical_reports\/2006\/RAND_TR362.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0205","first-page":"27","article-title":"Convulsions from psilocybe mushroom poisoning","volume":"5","author":"Mccawley","year":"1962","journal-title":"Proc. West. Pharmacol. Soc."},{"key":"10.1016\/j.yrtph.2011.01.006_b0210","first-page":"339","article-title":"The relation of expectation and mood to psilocybin reactions: a questionnaire study","volume":"5","author":"Metzner","year":"1965","journal-title":"Psychedelic Rev."},{"key":"10.1016\/j.yrtph.2011.01.006_b0215","unstructured":"Mixmag., 2005. Mixmag Drug Survey 2000\u20132005 \u2013 evidence includes personal communication from Dr. Luke Mitcheson. Reference cited in EMCDDA report. Website: <http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_31215_EN_TP_Hallucinogenic_mushrooms.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0220","unstructured":"Monshouwer, K, Dorsselaer, S, Gorter, A, Verdurmen, J., Vollebergh, W., 2004. Jeugd en riskant gedrag; kerngegevens uit het peilstationsonderzoek 2003. Trimbos instituut Utrecht."},{"key":"10.1016\/j.yrtph.2011.01.006_b0225","unstructured":"NFI 2007. Personal communication. Briefing by Nederlands Forensic Instituut (NFI; Dutch Forensic Institute). May 2007."},{"key":"10.1016\/j.yrtph.2011.01.006_b0230","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/15622970410029908","article-title":"Khat and mushrooms associated with psychosis","volume":"5","author":"Nielen","year":"2004","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.yrtph.2011.01.006_b0235","unstructured":"Nordic Council of Ministers 2009. Occurrence and use of hallucinogenic mushrooms containing psilocybin alkaloids. Copenhagen. Website: <http:\/\/www.norden.org\/en\/publications\/publications\/2008-606\/at_download\/publicationfile> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0240","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2011.01.006_b0245","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/S0140-6736(10)61462-6","article-title":"Drug harms in the UK: a multicriteria decision analysis","volume":"376","author":"Nutt","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.yrtph.2011.01.006_b0250","unstructured":"O\u2019Brien, CP., 1996. Drug addiction and drug abuse. In: Hardman, J.J., Limbird, L. (Ed.), Goodman and Guilman\u2019s the pharmacological basis of therapeutics, ninth ed., pp. 557\u2013577."},{"key":"10.1016\/j.yrtph.2011.01.006_b0255","unstructured":"Pechnick, R.N., Ungerleider, J.T., 2005. Hallucinogens, In: Lowinson, J. H., Ruiz, P., Millman, R. B., Langrod, J. G. (Ed.), Substance Abuse A Comprehensive Textbook, fourth ed. pp. 313\u2013323."},{"key":"10.1016\/j.yrtph.2011.01.006_b0260","unstructured":"Quetin, A.M., 1960. La psilocybine en psychiatrie clinique et experimentale. Paris: Medical dissertation."},{"key":"10.1016\/j.yrtph.2011.01.006_b0265","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/10826080701772363","article-title":"Between prohibitions: patterns and meanings of magic mushroom use in the UK","volume":"43","author":"Riley","year":"2008","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.yrtph.2011.01.006_b0270","unstructured":"Roe, S., 2005. Drug Misuse Declared: findings from the 2004\/05 British Crime Survey, HOSB 16\/05 (London: Home Office). Website: <http:\/\/rds.homeoffice.gov.uk\/rds\/pdfs05\/hosb1605.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0275","first-page":"394","article-title":"Poisonings resulting from the ingestion of magic mushrooms in Krakow","volume":"62","author":"Satora","year":"2005","journal-title":"Przegl. Lek."},{"key":"10.1016\/j.yrtph.2011.01.006_b0280","unstructured":"Shroomery. 2007. The Shroomery \u2013 <http:\/\/www.shroomery.org>."},{"key":"10.1016\/j.yrtph.2011.01.006_b0285","doi-asserted-by":"crossref","first-page":"182","DOI":"10.5694\/j.1326-5377.1984.tb103978.x","article-title":"Intravenous injection of mushrooms","volume":"140","author":"Sivyer","year":"1984","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.yrtph.2011.01.006_b0290","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.drugalcdep.2006.08.008","article-title":"Who is becoming hallucinogen dependent soon after hallucinogen use starts?","volume":"87","author":"Stone","year":"2007","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.yrtph.2011.01.006_b0295","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/mpr.188","article-title":"Evidence for a hallucinogen dependence syndrome developing soon after onset of hallucinogen use during adolescence","volume":"15","author":"Stone","year":"2006","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.yrtph.2011.01.006_b0300","article-title":"Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies","author":"Studerus","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.yrtph.2011.01.006_b0305","unstructured":"Trimbos., 2010. Monitor drugsincidenten. Fact sheet 2009. Website: <http:\/\/www.drugsincidenten.nl\/documents\/PDFs\/Factsheet%20monitor%20drugsincidenten%20.pdf> (retrieved November 2010)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000317249","article-title":"Ranking the harm of alcohol, tobacco and illicit drugs for the individual and the population","volume":"16","author":"van Amsterdam","year":"2010","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.yrtph.2011.01.006_b0315","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.lfs.2006.06.010","article-title":"Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction","volume":"79","author":"van Amsterdam","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2011.01.006_b0320","first-page":"515","article-title":"Cannabis als risicofactor van schizofrenie","volume":"46","author":"van Amsterdam","year":"2004","journal-title":"Tijdschr. Psychologie"},{"key":"10.1016\/j.yrtph.2011.01.006_b0325","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0361-9230(01)00646-3","article-title":"A systems model of altered consciousness: integrating natural and drug-induced psychoses","volume":"56","author":"Vollenweider","year":"2001","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.yrtph.2011.01.006_b0330","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1097\/00001756-199812010-00024","article-title":"Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action","volume":"9","author":"Vollenweider","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.yrtph.2011.01.006_b0335","unstructured":"VWA 2007. Briefing of VWA (Dutch Food and Consumer Product Safety Authority)."},{"key":"10.1016\/j.yrtph.2011.01.006_b0340","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1177\/0269881106065859","article-title":"Effects of psilocybin on time perception and temporal control of behaviour in humans","volume":"21","author":"Wittmann","year":"2007","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.yrtph.2011.01.006_b0345","series-title":"Drug, Set, and Setting: The Basis for Controlled Intoxicant Use","author":"Zinberg","year":"2010"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230011000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230011000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T18:34:26Z","timestamp":1592246066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230011000080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S0273230011000080"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2011.01.006","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}